News in brief: Zelira plots ASX return; Epsilon revenue soars by Steve Jones November 3, 2026November 3, 2026 Zelira Therapeutics has said it will lodge its delayed half year and full year financial reports […]
Cannabis executive salaries: who earned what in FY26 by Adam Sheldon October 15, 2026October 19, 2026
‘The future of cannabis medicine’: Epsilon, Puro and Helix develop B2B product by Adam Sheldon September 15, 2026September 15, 2026
Epsilon Healthcare reports record receipts as manufacturing expands by Steve Jones July 30, 2026July 30, 2026
Epsilon Healthcare and former chairman settle legal dispute by Steve Jones April 14, 2026April 14, 2026
News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026June 8, 2026
Epsilon posts strongest December quarter following ASX reinstatement by Adam Sheldon January 28, 2026January 28, 2026
Epsilon Healthcare resumes trading on ASX after two-year suspension by Steve Jones December 19, 2025December 22, 2025
